Electra D. Paskett, PhD | College of ...

Dr. Electra D. Paskett, PhD

Claim this profile

Ohio State University Comprehensive Cancer Center

Studies Cancer
Studies Colorectal Cancer
7 reported clinical trials
12 drugs studied

Affiliated Hospitals

Image of trial facility.

Ohio State University Comprehensive Cancer Center

Image of trial facility.

Ohio State University Medical Center

Clinical Trials Electra D. Paskett, PhD is currently running

Image of trial facility.

Outreach Project

for Cancer Clinical Trials

This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial/ethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials. Unfortunately, participation in clinical trials is not equal across all racial and ethnic groups, limiting progress against cancer in all population groups and further widening the disparity gap. To change this picture, concerted effort needs to be directed both at the communities at risk for being left out of trials and the systems that cause the disparities at all levels involved in accrual to clinical trials. The CUSP2CT project may have the potential to increase referral and accrual of racial/ethnic minorities to prevention/control and treatment trials.

Recruiting

1 award

N/A

Image of trial facility.

Screening Program

for Cancer

This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counties in Central Ohio. In Ohio, incidence and mortality rates for breast, cervical and CRC are higher than or similar to the national average; in addition, underserved populations - minority, rural and low-income women - have higher rates of these cancers. Screening can detect precancerous colorectal and cervical lesions and other early-stage cancers when treatment is less intensive and more successful and is known to reduce mortality rates for breast, cervical, and CRC, however many of these women lack access to health care and screenings. This MLI includes clinic-based components, such as patient education, as well as community-based strategies, such as media programs and training health workers, that can increase rates of guideline-recommended breast, cervical and CRC screening and follow-ups in underserved populations. The OSU SCREEN Community Program may be an effective way to improve breast, cervical and CRC screenings among underserved women in Ohio.

Recruiting

1 award

N/A

More about Electra D. Paskett, PhD

Clinical Trial Related

3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials

Treatments Electra D. Paskett, PhD has experience with

  • Educational Intervention
  • The Ohio State University (OSU) SCREEN Community Program
  • HPV Vaccine
  • Reminder
  • CUSP2CT Project
  • HPV Education Programs

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Electra D. Paskett, PhD specialize in?

Is Electra D. Paskett, PhD currently recruiting for clinical trials?

Are there any treatments that Electra D. Paskett, PhD has studied deeply?

What is the best way to schedule an appointment with Electra D. Paskett, PhD?

What is the office address of Electra D. Paskett, PhD?

Is there any support for travel costs?